Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients | Zendy

Katherine Allinson | Zendy; Hedwig Kolve | Zendy; H. Gumbinger | Zendy; H. Josef Vormoor | Zendy; Karoline Ehlert | Zendy; Andreas H. Groll | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients

Author(s) -

Katherine Allinson,

Hedwig Kolve,

H. Gumbinger,

H. Josef Vormoor,

Karoline Ehlert,

Andreas H. Groll

Publication year - 2008

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkm521

Subject(s) - medicine , voriconazole , contraindication , surgery , transplantation , immunosuppression , adverse effect , regimen , gastroenterology , antifungal , pathology , dermatology , alternative medicine

Presumed or proven invasive pulmonary aspergillosis (IPA) is an important cause of infectious morbidity in patients with acute leukaemia. Although prior IPA is not a contraindication for subsequent allogeneic haematopoietic stem cell transplantation (HSCT), its management during granulocytopenia and immunosuppression remains challenging.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research